Search results for "DAS"

showing 10 items of 4164 documents

Cine epistolar: imaginación y política del intercambio estético

2014

Resumen: Este articulo estudia las implicaciones politicas del intercambio estetico, mediante el estudio de un proyecto de correspondencias filmicas desarrollado por el Centro de Cultura Contemporanea de Barcelona (CCCB), entre 2005 y 2011. Propone el intercambio epistolar como una forma de interpelacion cinematografica capaz de crear afinidades geopoliticas a traves de la puesta en comun y el ensamblaje de realidades sensibles. En definitiva, el objetivo del presente estudio es investigar el potencial del intercambio estetico como ejercicio de imaginacion politica, planteando la posibilidad de un valor de uso de la imagen mas alla de la economia politica neoliberal. Abstract: This article …

Cultural StudiesHistoria del cine; Estudios Culturales; FilosofíaLinguistics and LanguageHistoryLiterature and Literary TheoryCommunicationmedia_common.quotation_subjectArtEstudios CulturalesCine epistolarCine epistolar; Todas las cartas; CCCBLanguage and LinguisticsHistoria del cineTodas las cartasFilosofíaCCCBHumanitiesmedia_common
researchProduct

La consagración de los derechos fundamentales: de principios generales a texto fundacional de la Unión Europea

2014

<p>El autor argumenta que el reconocimiento formal de los derechos fundamentales como parte de los fundamentos comunes de la UE mediante la remisión a la Carta de los Derechos Fundamentales en el Tratado de Lisboa (otorgándole carácter vinculante y, por ende, elevando su rango y confiriéndole el mismo valor jurídico que los Tratados) ha proporcionado una mayor apariencia constitucional a la UE, pero no un nivel más generoso de protección y de disfrute de la ciudadanía. En efecto, además de haber prescindido de garantías específicas, la Carta de la UE ha introducido diversas asimetrías inaceptables, tales como la quiebra del principio de indivisibilidad (los derechos civiles y los soci…

Cultural StudiesHistoryderechos fundamentales indivisiblesEconomics Econometrics and Finance (miscellaneous)lcsh:International relationslcsh:Political sciencelcsh:KJ-KKZlcsh:Law of Europearmonización y principio favor libertatisdiálogo judicial y sinergiasefectividad (de la carta de la ue) versus medidas de austeridadadhesión a los instrumentos del consejo de europaPolitical Science and International RelationsLawlcsh:Jlcsh:JZ2-6530
researchProduct

La industria del cómic en España: radiografía de ¿un mito o una realidad?

2011

In spite of the importance of figures referred to published titles, or number of copies printed, which help to set publishing strategies and to really know the comic situation in Spain, there are no liable data. We are giving in this article, some enlightening data along with some explanations related to the evolution of the market from 2001 to 2009. The different titles are grouped considering the place they come from (Europe, Asia, United States…), along with their format (album, book, magazine, comic-book…). Using all this information, we can deduce evolution lines, tendencies, futures perspectives in an industry that, despite its precariousness, is facing an increasing number of copies …

Cultural StudiesHistoryformatsSociology and Political Scienceventaslcsh:AComicstiradasindustriaGeneral WorkssalesApercentagesEconomic historyformatosimport-exportMercadoimportación-exportaciónindustrybusiness.industryGeneral Arts and HumanitiesporcentajesMarketproducción españolaEconomyeditions and print-runPublishingSpiteSpanish productionlcsh:General WorksbusinessSettlement (litigation)Futures contractArbor: Ciencia, Pensamiento y Cultura
researchProduct

Virus entéricos humanos en alimentos: detección y métodos de inactivación

2020

[ES] Los principales patógenos víricos que podemos adquirir ingiriendo alimentos contaminados son los norovirus, el virus de la hepatitis A y el virus de la hepatitis E que se propagan principalmente a través de la vía fecal oral. En los últimos años, la incidencia de brotes de transmisión alimentaria causados por estos patógenos ha experimentado un aumento considerable, en parte debido al comercio globalizado y a los cambios en los hábitos de consumo. Las matrices alimentarias que mayor riesgo representan para el consumidor son los moluscos bivalvos, vegetales de IV gama, frutas tipo baya y platos listos para comer. Actualmente las técnicas moleculares son las más habituales para la detecc…

Cultural StudiesSociology and Political ScienceFood industryViral inactivationmolecular methodsFoodborne virusesBiologymedicine.disease_causeGeneral WorksFood safety03 medical and health sciencesseguridad alimentariaAmedicineenvases virucidas030304 developmental biologyinactivación víricaInfectivityviral inactivationmetagenomicscompuestos virucidas0303 health sciencesantiviral packaging030306 microbiologybusiness.industryvirus entéricosGeneral Arts and Humanitiesdigestive oral and skin physiologyfoodborne virusesFoodborne outbreakHepatitis AFood safetymedicine.diseaseVirologyantiviral compoundsVirusMolecular methodsfood safetymétodos molecularesAliments ContaminacióViral genomesAntiviral packagingmetagenómicaNorovirusAntiviral compoundsMetagenomicsbusinessContaminated foodArbor
researchProduct

Fabrication of quercetin and curcumin bionanovesicles for the prevention and rapid regeneration of full-thickness skin defects on mice

2013

In the present work biocompatible quercetin and curcumin nanovesicles were developed as a novel approach to prevent and restore skin tissue defects on chronic cutaneous pathologies. Stable and suitable quercetin- and curcumin-loaded phospholipid vesicles, namely liposomes and penetration enhancer-containing vesicles (PEVs), were prepared. Vesicles were made from a highly biocompatible mixture of phospholipids and alternatively a natural polyphenol, quercetin or curcumin. Liposomes were obtained by adding water, while PEVs by adding polyethylene glycol 400 and Oramix®CG110 to the water phase. Transmission electron microscopy, cryogenic-transmission electron microscopy and small- and wide-ang…

CurcuminMaterials scienceStatic ElectricitySus scrofaBiomedical EngineeringPolyethylene glycolBiochemistryBiomaterialsMicechemistry.chemical_compoundX-Ray DiffractionScattering Small AnglePEG ratioAnimalsEdemaRegenerationParticle SizeMolecular BiologyPeroxidaseSkinMice Inbred ICRLiposomeVesicleGeneral MedicineIn vitroDisease Models AnimalchemistryBiochemistryLiposomesCurcuminBiophysicsNanoparticlesFemaleQuercetinQuercetinWound healingBiotechnologyActa Biomaterialia
researchProduct

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with…

2017

Summary Background We ran a compassionate use nationwide programme (ABACUS) to provide access to ombitasvir, paritaprevir, and ritonavir, with dasabuvir, plus ribavirin for hepatitis C virus (HCV) genotype 1 infection and ombitasvir, paritaprevir, and ritonavir, plus ribavirin for HCV genotype 4 infection in patients with cirrhosis at high risk of decompensation while approval of these regimens was pending in Italy. Methods In this prospective observational study, we collected data from a compassionate use nationwide programme from March 17, 2014, to May 28, 2015. Patients with HCV genotype 1 infection and cirrhosis at high risk of decompensation were given coformulated ombitasvir (25 mg), …

CyclopropanesCompassionate Use TrialsLiver CirrhosisMalechemistry.chemical_compound0302 clinical medicine2-NaphthylamineHCV direct-acting antiviral mixed cryoglobulinemia RBVAnilides030212 general & internal medicineLongitudinal StudiesProspective StudiesChronicAdult; Aged; Anilides; Antiviral Agents; Carbamates; Compassionate Use Trials; Drug Therapy Combination; Female; Genotype; Hepatitis C Chronic; Humans; Liver Cirrhosis; Longitudinal Studies; Macrocyclic Compounds; Male; Middle Aged; Prospective Studies; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; UracilSettore MED/12 - GastroenterologiaSulfonamidesDasabuvirHCV DAAGastroenterologyvirus diseasesValineMiddle AgedSettore MED/07 - Microbiologia e Microbiologia ClinicaHepatitis CTreatment OutcomeGastroenterology; HepatologyCombinationDrug Therapy Combination030211 gastroenterology & hepatologyFemalemedicine.drugAdultmedicine.medical_specialtyMacrocyclic CompoundsProlineGenotypeLactams MacrocyclicAdult; Aged; Anilides; Antiviral Agents; Carbamates; Compassionate Use Trials; Drug Therapy Combination; Female; Genotype; Hepatitis C Chronic; Humans; Liver Cirrhosis; Longitudinal Studies; Macrocyclic Compounds; Male; Middle Aged; Prospective Studies; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Hepatology; GastroenterologyHepatitis C virus genotype 1 Hepatitis C virus genotype 4 decompensated liver cirrhosis antiviral therapy dasabuvir ombitasvir paritaprevirHepatology; GastroenterologyAntiviral Agents03 medical and health sciencesDrug TherapyInternal medicineRibavirinmedicineHumansDecompensationAdverse effectUracilAgedRitonavirHepatologybusiness.industryRibavirinHepatitis C ChronicVirologyOmbitasvirClinical trialchemistryParitaprevirRitonavirCarbamatesbusiness
researchProduct

Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

2018

Purpose: To analyse safety and efficacy of treatment based on ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in the sub-group of GT1 patients older than 65 years. Methods: We collected data extracted from the ABACUS compassionate-use nationwide Italian programme, in patients with cirrhosis due to hepatitis C virus (HCV) Genotype-1 (GT1) or 4 and at high risk of decompensation. GT1-HCV-infected patients received once-daily ombitasvir/paritaprevir, with the pharmacokinetic enhancer ritonavir (25/150/100 mg) and twice-daily dasabuvir (250 mg) plus Ribavirin (RBV) (OBV/PTV/r + DSV + RBV) for 12 (GT1b) or 24 (GT1a) weeks. Endpoints were to evaluate safety and efficacy, the latter def…

CyclopropanesLiver CirrhosisMaleCirrhosis;Dasabuvir;Elderly;Ombitasvir;ParitaprevirCirrhosis; Dasabuvir; Elderly; Ombitasvir; Paritaprevir; Aged; Aged; 80 and over; Anilides; Antiviral Agents; Biomarkers; Carbamates; Female; Hepacivirus; Hepatitis C; Chronic; Humans; Liver Cirrhosis; Macrocyclic Compounds; Male; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Drug Therapy; Combination; GenotypeParitaprevirCirrhosis Dasabuvir Elderly Ombitasvir Paritaprevir Microbiology (medical) Infectious DiseasesCirrhosis; Dasabuvir; Elderly; Ombitasvir; Paritaprevir; Aged; Aged 80 and over; Anilides; Antiviral Agents; Biomarkers; Carbamates; Female; Hepacivirus; Hepatitis C Chronic; Humans; Liver Cirrhosis; Macrocyclic Compounds; Male; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Drug Therapy Combination; Genotype; Microbiology (medical); Infectious DiseasesHepacivirusGastroenterologychemistry.chemical_compound0302 clinical medicineElderly2-Naphthylamine80 and overMedicineAnilides030212 general & internal medicineChronicAged 80 and overSulfonamidesDasabuvirValineGeneral MedicineHepatitis CHepatitis CTreatment OutcomeInfectious DiseasesCirrhosisCombination030211 gastroenterology & hepatologyDrug Therapy CombinationFemaleDasabuvirMacrocyclic CompoundCirrhosis; Dasabuvir; Elderly; Ombitasvir; Paritaprevir; Microbiology (medical); Infectious Diseasesmedicine.drugHumanMicrobiology (medical)medicine.medical_specialtyMacrocyclic CompoundsProlineGenotypeLactams MacrocyclicSettore MED/12 - GASTROENTEROLOGIALiver CirrhosiSulfonamideAntiviral Agents03 medical and health sciencesDrug TherapyInternal medicineRibavirinHumansDecompensationUracilAgedHepatitisAntiviral AgentCirrhosiHepaciviruRitonavirbusiness.industryRibavirinSettore MED/09 - MEDICINA INTERNAAnilideBiomarkerHepatitis C Chronicmedicine.diseaseCirrhosis; Dasabuvir; Elderly; Ombitasvir; Paritaprevir; Aged; Aged 80 and over; Anilides; Antiviral Agents; Biomarkers; Carbamates; Female; Hepacivirus; Hepatitis C Chronic; Humans; Liver Cirrhosis; Macrocyclic Compounds; Male; Ribavirin; Ritonavir; Sulfonamides; Treatment Outcome; Uracil; Drug Therapy Combination; GenotypeOmbitasvirOmbitasvirchemistryParitaprevirCarbamateRitonavirCarbamatesbusinessBiomarkers
researchProduct

Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepa…

2017

Summary Real-world studies are relevant to complement clinical trials on novel antiviral therapies against chronic hepatitis C; however, clinical practice data are currently limited. This study investigated effectiveness and safety of ombitasvir/paritaprevir/ritonavir (OBV/PTV/r)±dasabuvir (DSV)±ribavirin (RBV) for treatment of HCV genotype (GT) 1 and GT4 infection in a large real-world cohort. The German Hepatitis C Registry is an observational cohort study prospectively collecting clinical practice data on direct-acting antiviral therapies. Patients with GT1/4 infection treated with OBV/PTV/r±DSV±RBV were analysed. Effectiveness was assessed by sustained virologic response in 558 patients…

CyclopropanesLiver CirrhosisMaleHepacivirusSeverity of Illness IndexCohort Studieschemistry.chemical_compound0302 clinical medicine2-NaphthylamineGermanyMedicineAnilides030212 general & internal medicineSulfonamidesDasabuvirValineHepatitis CMiddle AgedViral LoadInfectious DiseasesTreatment Outcome030211 gastroenterology & hepatologyDrug Therapy CombinationFemalemedicine.drugAdultmedicine.medical_specialtyMacrocyclic CompoundsGenotypeProlineLactams Macrocyclic03 medical and health sciencesVirologyOmbitasvir/paritaprevir/ritonavirInternal medicineHumansUracilAgedRitonavirHepatologybusiness.industryHepatitis C Chronicmedicine.diseaseVirologyOmbitasvirDiscontinuationRegimenchemistryParitaprevirRitonavirCarbamatesbusinessJournal of viral hepatitis
researchProduct

Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A met…

2017

The direct-acting antiviral regimen of ombitasvir (OBV)/paritaprevir (PTV)/ritonavir (r) ± dasabuvir (DSV) ± ribavirin (RBV) demonstrated high rates of sustained viral response at post-treatment week 12 (SVR12) in clinical trials for treatment of hepatitis C virus (HCV) genotypes (GT) 1 and 4. To confirm the effectiveness of this regimen in the real world, we conducted meta-analyses of published literature on 30 April 2016. Freeman-Tukey transformation determined the SVR rate within GTs 1a, 1b, and 4, as well as specific SVR rates by cirrhosis or prior treatment experience status. Rates of virologic relapse, hepatic decompensation, drug discontinuation, and serious adverse events were also …

CyclopropanesLiver CirrhosisSustained Virologic ResponseHCV genotypes 1 and 4ComorbidityHepacivirusmedicine.disease_causeGastroenterologymeta-analysichemistry.chemical_compound0302 clinical medicineAnilides030212 general & internal medicineSulfonamidesDasabuvirValineHepatitis CViral LoadHepatitis Creal-world effectiveneInfectious DiseasesTreatment Outcome2D; 3D; HCV genotypes 1 and 4; hepatitis C; meta-analysis; real-world effectiveness; Hepatology; Infectious Diseases; Virology030211 gastroenterology & hepatologyDrug Therapy Combinationmedicine.drug3Dmedicine.medical_specialtyMacrocyclic CompoundsGenotypeProlineHepatitis C virusLactams MacrocyclicInfectious DiseaseAntiviral Agents03 medical and health sciencesInternal medicineVirologyRibavirinmedicineHumans2DRitonavirHepatologybusiness.industryRibavirinmedicine.diseaseOmbitasvirRegimenchemistryParitaprevirImmunologyRitonavirCarbamatesbusinessJournal of viral hepatitis
researchProduct

Review of the genus Valdasus Stål, 1860 (Heteroptera, Miridae, Cylapinae), with descriptions of four new species from Brazil, Ecuador and French Guia…

2020

The genus Valdasus Stål, 1860 is reviewed. Four species are described as new: Valdasus favrei n. sp., V. ferrerai n. sp., V. flavinotum n. sp., and V. henryi n. sp. V. erebeus Distant, 1883 and V. stygius Distant, 1883 are transferred again to Valdasus (original combination reestablished) from Peltidocylapus Poppius and they are redescribed along with the type species V. schoenherri Stål, 1860. Presence of V. bolivianus in Argentina is challenged after new analysis of female specimen mentioned in literature. 

CylapiniInsectaCylapinaeArthropodaZoologyHeteropteraHemipteraValdasusAnimalsAnimaliaEcology Evolution Behavior and SystematicsTaxonomynew speciesbiologyHeteropteraCylapinaeBiodiversitybiology.organism_classificationMiridaeFrench GuianaType speciesAnimal Science and ZoologyTaxonomy (biology)FemaleEcuadorMiridaeAnimal DistributionBrazil
researchProduct